Blue Trust Inc’s Amedisys AMED Stock Holding History

Blue Trust Inc’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-225	Closed	-$20.7K	–	2447
2024 Q3	$20.7K	Buy	225 +178	+379%	+$17.4K	﹤0.01%	1927
2024 Q2	$4.33K	Buy	+47	New	+$4.36K	﹤0.01%	2243
2023 Q3	–	Sell	-9	Closed	-$1K	–	2015
2023 Q2	$1K	Sell	9 -4	-31%	-$328	﹤0.01%	1792
2023 Q1	$1K	Sell	13 -108	-89%	-$9.34K	﹤0.01%	2094
2022 Q4	$12K	Sell	121 -3	-2%	-$270	﹤0.01%	1465
2022 Q3	$13K	Buy	124 +84	+210%	+$10K	﹤0.01%	1250
2022 Q2	$7K	Buy	+40	New	+$5.11K	﹤0.01%	1314

Other funds holding AMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Blue Trust Inc's AMED Position: Q4 2024 in Review

Blue Trust Inc sold out of Amedisys (AMED) in Q4 2024, closing a stake of 225 shares — an estimated $20.7K sold.

Blue Trust Inc first reported a position in AMED in Q2 2022 and held it in 7 quarters. The position peaked at $20.7K in Q3 2024. 290 funds tracked by Wall St. Rank hold AMED as of Q4 2024.

Blue Trust Inc reported no remaining Amedisys position as of Q4 2024 after selling out during the quarter.
Blue Trust Inc sold 225 Amedisys shares in Q4 2024, an estimated $20.7K.
Blue Trust Inc first reported a position in Amedisys in Q2 2022 and held it in 7 quarters.
Blue Trust Inc's Amedisys position peaked at $20.7K in Q3 2024.
290 funds tracked by Wall St. Rank held Amedisys as of Q4 2024.

Based on Blue Trust Inc's 13F filing for Q4 2024, filed 22 Jan 2025.